ArQule Profit Margin 2006-2018 | ARQL

Current and historical gross margin, operating margin and net profit margin for ArQule (ARQL) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. ArQule net profit margin as of December 31, 2018 is -60.09%.
ArQule Annual Profit Margins
ArQule Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.525B $0.026B
ArQule, Inc. is a biotechnology company engaged in the research and development of next-generation, small-molecule cancer therapeutics. The Company's targeted, broad-spectrum products and research programs are focused on key biological processes that are central to cancer. ArQule's lead clinical-stage products have been generated from two scientific platforms: Cancer Survival Protein modulation and Activated Checkpoint Therapy. The Cancer Survival Protein modulation platform has generated a clinical-stage product that mediates its effects by inhibiting the activity of a molecule known as c-Met, which plays multiple roles in cancer cell growth, survival, invasion, angiogenesis and metastasis. The ACT platform is designed to kill cancer cells selectively while sparing normal cells through direct activation of DNA damage response/checkpoint pathways. The Company's lead ACT program, based on the E2F-1 pathway, is partnered with Roche.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $46.886B 31.19
Takeda Pharmaceutical (TAK) Japan $32.716B 12.10
Grifols (GRFS) Spain $12.878B 15.61
Ionis Pharmaceuticals (IONS) United States $10.920B 33.86
Jazz Pharmaceuticals (JAZZ) Ireland $7.794B 11.16
Neurocrine Biosciences (NBIX) United States $7.730B 500.65
Sage Therapeutics (SAGE) United States $7.380B 0.00
Tilray (TLRY) United States $6.257B 0.00
Catalent (CTLT) United States $5.923B 24.80
Nektar Therapeutics (NKTR) United States $5.601B 8.94
United Therapeutics (UTHR) United States $5.282B 8.98
FibroGen (FGEN) United States $4.533B 0.00
Taro Pharmaceutical Industries (TARO) Israel $4.247B 13.67
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $4.197B 0.00
Zogenix (ZGNX) United States $2.223B 0.00
PTC Therapeutics (PTCT) United States $2.194B 0.00
Portola Pharmaceuticals (PTLA) United States $2.136B 0.00
Aerie Pharmaceuticals (AERI) United States $2.128B 0.00
Ironwood Pharmaceuticals (IRWD) United States $2.106B 0.00
Madrigal Pharmaceuticals (MDGL) United States $2.070B 0.00
USANA Health Sciences (USNA) United States $2.010B 16.87
Endo (ENDP) Ireland $1.869B 2.88
Heron Therapeutics (HRTX) United States $1.859B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.855B 23.10
Xencor (XNCR) United States $1.685B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.674B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.576B 136.50
Corcept Therapeutics (CORT) United States $1.281B 18.62
Theravance Biopharma (TBPH) Cayman Islands $1.280B 0.00
TherapeuticsMD (TXMD) United States $1.252B 0.00
Esperion Therapeutics (ESPR) United States $1.110B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.063B 0.00
Tricida (TCDA) United States $1.009B 0.00
Radius Health (RDUS) United States $0.866B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.813B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.591B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.569B 0.00
Odonate Therapeutics (ODT) United States $0.560B 0.00
GlycoMimetics (GLYC) United States $0.560B 0.00
ChemoCentryx (CCXI) United States $0.551B 0.00
Dermira (DERM) United States $0.550B 0.00
Collegium Pharmaceutical (COLL) United States $0.527B 0.00
Forty Seven (FTSV) United States $0.508B 0.00
KalVista Pharmaceuticals (KALV) United States $0.486B 0.00
Akebia Therapeutics (AKBA) United States $0.479B 0.00
Flexion Therapeutics (FLXN) United States $0.475B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.473B 27.90
Siga Technologies (SIGA) United States $0.466B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.454B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.413B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.410B 0.00
TCR2 THERAPTCS (TCRR) United States $0.407B 0.00
Translate Bio (TBIO) United States $0.406B 0.00
Aptorum Group (APM) China $0.381B 0.00
OptiNose (OPTN) United States $0.379B 0.00
Concert Pharmaceuticals (CNCE) United States $0.365B 0.00
ImmunoGen (IMGN) United States $0.360B 0.00
Karyopharm Therapeutics (KPTI) United States $0.331B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.313B 11.60
Verrica Pharmaceuticals (VRCA) United States $0.297B 0.00
CASI Pharmaceuticals (CASI) United States $0.296B 0.00
Minerva Neurosciences (NERV) United States $0.296B 0.00
Immune Design (IMDZ) United States $0.283B 0.00
Lannett Co Inc (LCI) United States $0.281B 2.61
Mast Therapeutics (SVRA) United States $0.278B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.272B 0.00
Xeris Pharmaceuticals (XERS) United States $0.268B 0.00
Majesco Entertainment (PTE) United States $0.266B 0.00
Aclaris Therapeutics (ACRS) United States $0.253B 0.00
Affimed (AFMD) Germany $0.250B 0.00
Calithera Biosciences (CALA) United States $0.249B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.249B 0.00
HARPOON THERAPT (HARP) United States $0.249B 0.00
Dova Pharmaceuticals (DOVA) United States $0.248B 0.00
ElectroCore (ECOR) United States $0.239B 0.00
Opexa Therapeutics (ACER) United States $0.231B 0.00
MEI Pharma (MEIP) United States $0.217B 0.00
Recro Pharma (REPH) United States $0.214B 0.00
Tyme Technologies (TYME) United States $0.213B 0.00
Ardelyx (ARDX) United States $0.210B 0.00
Galectin Therapeutics (GALT) United States $0.208B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.206B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.202B 0.00
Molecular Templates (MTEM) United States $0.199B 0.00
Jounce Therapeutics (JNCE) United States $0.198B 0.00
Aldeyra Therapeutics (ALDX) United States $0.196B 0.00
Redhill Biopharma (RDHL) Israel $0.186B 0.00
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.186B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.183B 0.00
IMV INC (IMV) Canada $0.182B 0.00
Aratana Therapeutics (PETX) United States $0.180B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.179B 0.00
Nature's Sunshine Products (NATR) United States $0.176B 182.20
Ocular Therapeutix (OCUL) United States $0.169B 0.00
Neos Therapeutics (NEOS) United States $0.163B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.162B 0.00
Aquestive Therapeutics (AQST) United States $0.155B 0.00
Neon Therapeutics (NTGN) United States $0.151B 0.00
MediWound (MDWD) Israel $0.140B 0.00
ProNAi Therapeutics (SRRA) Canada $0.139B 0.00
China SXT Pharmaceuticals (SXTC) China $0.138B 0.00
Cardiome Pharma (CORV) Canada $0.123B 0.00
Champions Oncology (CSBR) United States $0.117B 0.00
DURECT (DRRX) United States $0.113B 0.00
Zafgen (ZFGN) United States $0.106B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.106B 0.00
Adherex Technologies (FENC) United States $0.104B 0.00
Iterum Therapeutics (ITRM) Ireland $0.101B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.101B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.100B 0.00
Infinity Pharmaceuticals (INFI) United States $0.100B 0.00
Nivalis Therapeutics (ALPN) United States $0.095B 0.00
Avenue Therapeutics (ATXI) United States $0.089B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.088B 0.00
Otonomy (OTIC) United States $0.084B 0.00
Natural Alternatives (NAII) United States $0.082B 8.06
SCYNEXIS (SCYX) United States $0.079B 0.00
Genocea Biosciences (GNCA) United States $0.075B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.066B 0.00
Forward Pharma (FWP) Denmark $0.057B 0.00
CTI BioPharma (CTIC) United States $0.056B 0.00
Bio-Path Holdings (BPTH) United States $0.055B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.055B 0.00
KemPharm (KMPH) United States $0.053B 0.00
Lipocine (LPCN) United States $0.053B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.052B 0.00
Capnia (SLNO) United States $0.052B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.050B 0.00
BioLineRx (BLRX) Israel $0.048B 0.00
Melinta Therapeutics (MLNT) United States $0.046B 0.00
Mannatechorporated (MTEX) United States $0.043B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.040B 0.00
NOVAN INC (NOVN) United States $0.039B 0.00
ProPhase Labs (PRPH) United States $0.037B 0.00
ContraFect (CFRX) United States $0.035B 0.00
HANCOCK JAFFE (HJLI) United States $0.034B 0.00
Achaogen (AKAO) United States $0.033B 0.00
Heat Biologics (HTBX) United States $0.029B 0.00
PharmAthene (ALT) United States $0.026B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.025B 0.00
Shineco (TYHT) China $0.025B 4.23
Onconova Therapeutics (ONTX) United States $0.024B 0.00
Citius Pharmaceuticals (CTXR) United States $0.024B 0.00
Biomerica (BMRA) United States $0.023B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.022B 0.00
ESSA Pharma (EPIX) Canada $0.022B 0.00
Jaguar Animal Health (JAGX) United States $0.022B 0.00
Pain Therapeutics (PTIE) United States $0.021B 0.00
Cyanotech (CYAN) United States $0.019B 0.00
Achieve Life Sciences (ACHV) United States $0.019B 0.00
Xenetic Biosciences (XBIO) United States $0.018B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.018B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.017B 0.00
VAXART, INC (VXRT) United States $0.017B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.014B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.013B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.012B 0.00
PRECISION THERAPEUTICS INC (AIPT) United States $0.012B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.012B 0.00
Regulus Therapeutics (RGLS) United States $0.011B 0.00
Midatech Pharma (MTP) United Kingdom $0.010B 0.00
Trillium Therapeutics (TRIL) Canada $0.010B 0.00
RXi Pharmaceuticals (PHIO) United States $0.008B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.006B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.006B 0.00
Intellipharmaceutics (IPCIF) Canada $0.004B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.000B 0.00
Bio Blast Pharma (ORPN) Israel $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00